Altamira Therapeutics Ltd.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$7,270,038 over the previous period. Total operating expenses were $6,539,843.
Profit Margin
| 2014 | 3.00M | -18.18M | -604.35% |
|---|---|---|---|
| 2015 | -67K | -29.70M | 44335.82% |
| 2016 | -414K | -30.66M | 7406.34% |
| 2017 | 322K | -24.40M | -7580.58% |
| 2018 | 1.26M | -11.49M | -908.09% |
| 2019 | -56K | -6.63M | 11842.68% |
| 2020 | 174.47K | -8.20M | -4699.91% |
| 2021 | 63.88K | -17.39M | -27222.33% |
| 2022 | 305.61K | -26.52M | -8680.31% |
| 2023 | 0 | -7.27M |
EARS Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 305.61K | 63.88K | 174.47K | -56K | 1.26M | 322K | -414K | -67K | 3.00M |
Cost of revenue | 0 | 1.44M | 2.24M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | -1.13M | -2.17M | 174.47K | -56K | 1.26M | 322K | -414K | -67K | 3.00M |
Operating exp. | ||||||||||
Research and development | 3.03M | 19.67M | 8.93M | 2.86M | 3.32M | 6.68M | 19.21M | 24.77M | 26.53M | 17.70M |
Selling and marketing | 15.34K | 2.38M | 1.49M | 95.66K | 113.95K | 43.81K | 199.48K | 45.64K | 72.56K | 237.72K |
Total operating expenses | 6.53M | 24.99M | 14.92M | 5.45M | 7.25M | 10.95M | 24.36M | 30.22M | 30.87M | 22.19M |
Operating income | -5.91M | -26.13M | -17.09M | -5.28M | -7.25M | -10.95M | -24.36M | -30.22M | -30.87M | -22.19M |
Other income (expenses), net | -1.35M | -406.26K | -268.75K | -2.93M | 433.40K | 690.07K | -65.99K | 190.95K | 1.17M | 4.00M |
Income before tax | -7.27M | -26.53M | -17.36M | -8.22M | -6.82M | -11.33M | -24.42M | -30.79M | -29.70M | -18.18M |
Income tax expense | 0 | -10.32K | 21.62K | -21.28K | -193.83K | 162.17K | -17.77K | -131.05K | -84.77K | -892.17K |
Net income | -7.27M | -26.52M | -17.39M | -8.20M | -6.63M | -11.49M | -24.40M | -30.66M | -29.70M | -18.18M |
Earnings per share | ||||||||||
Basic EPS | -14.81 | -582.58 | -525.13 | -545.41 | -455.96 | -2.89K | -22.32K | -35.72K | -36.79K | -26.26K |
Diluted EPS | -14.8 | -582.58 | -525.13 | -545.41 | -455.96 | -2.89K | -22.32K | -35.72K | -36.79K | -26.26K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |